The fact that CD80 expression is increased by lyso-Gb3 in podocytes suggests that uCD80 may be an early marker of kidney injury in Fabry disease and also a marker of continued renal injury by glycolipids and future studies exploring the potential of uCD80 to reflect early, subclinical renal Fabry involvement are warranted. This evidence concerns the gene CD80 and Fabry disease.